Despite efforts by test maker Grail to highlight outcomes the company considers positive, some experts are warning against using the Galleri test and others like it.

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease.

Colorectal cancer is highly treatable when caught early—and FIT tests make screening easier than ever with a simple at‑home ...

The federal task force that shapes recommendations for cancer screenings, heart disease prevention and other preventive ...

Another challenge facing test designers is that early detection may not necessarily save lives. A crucial factor, and something that is still unknown about the new multi-cancer tests, is whether they ...

The results of a new study just came in.

Grail's blood test for detecting cancer early failed to meet its main goal in a giant study being conducted with England’s ...

Blood tests are helpful for monitoring your overall health. But research suggests they can also give us clues about the ...

The Alabama House on Tuesday passed two bills that would eliminate cost sharing for certain types of breast and prostate ...

A new analysis of colorectal cancer trends in the United States reveals a troubling shift in disease burden.Overall incidence ...

In 2026, an estimated 158,850 new cases of colorectal cancer (CRC) will be diagnosed, and 55,230 people will die from the ...